Clinical Trial Update: A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma [Phase 2]

View source ↗

Summary

This report concerns a Phase 2 safety and tolerability study of levalbuterol HFA metered-dose inhaler in subjects with asthma, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Levalbuterol HFA Metered Dose Inhaler (levalbuterol)

Snippet

Sponsor: Sumitomo Pharma America, Inc. | Conditions: Asthma | Phase 2 | Status: COMPLETED